EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia

Samuel P Soff iD, Samuel Ruder, James B Bussel iD

British Journal of Haematology · 2026-06 · 208 (6) · 1928-1930

DOI: 10.1111/bjh.70482 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 16.04.2026. Verfasst von Samuel P Soff und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Autoimmune Diseases. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Josephine Lawrence Hopkins Foundation, David and Elizabeth Sherman.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) is characterized by immune‐mediated platelet destruction and impaired platelet production. Both plasma/B cell‐producing anti‐platelet autoantibodies and autoreactive T cells lead to thrombocytopenia and treatment refractoriness. Conventional treatments often fail to induce sustained remission off treatment (SROT). Chimeric antigen receptor (CAR) T cell therapy, developed for haematological malignancies, has recently been explored in autoimmunity to target plasma/B cells, reducing autoantibody production. Early studies suggest potential for benefit in refractory autoimmune disease, including ITP. This nutshell review summarizes CAR T cell therapy in autoimmunity, especially refractory ITP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicReceptors, Chimeric AntigenImmunotherapy, AdoptiveAutoimmune DiseasesT-LymphocytesHumans

Stichwörter der Autor:innen

CAR T cellsimmune thrombocytopeniaimmunotherapy

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Samuel P Soff, James B Bussel

Förderung

  • Josephine Lawrence Hopkins Foundation
  • David and Elizabeth Sherman

Zitieren

APA

Soff, S. P., Ruder, S., & Bussel, J. B. (2026). Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia. British Journal of Haematology, 208(6), 1928-1930. https://doi.org/10.1111/bjh.70482

Vancouver

Soff SP, Ruder S, Bussel JB. Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia. British Journal of Haematology. 2026;208(6):1928-1930. doi:10.1111/bjh.70482

BibTeX
@article{Soff2026,
  author = {Soff, Samuel P and Ruder, Samuel and Bussel, James B},
  title = {Chimeric antigen receptor T cells for autoimmune diseases, in particular immune thrombocytopenia},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {208},
  number = {6},
  pages = {1928--1930},
  doi = {10.1111/bjh.70482}
}
Kostenlos starten →